These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 9408001

  • 1. PACAP-27 causes negative and positive dromotropic effects in anesthetized dogs.
    Hirose M, Furukawa Y, Nagashima Y, Lakhe M, Miyashita Y, Chiba S.
    Eur J Pharmacol; 1997 Oct 29; 338(1):35-42. PubMed ID: 9408001
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenylate cyclase-activating polypeptide-27 causes a biphasic chronotropic effect and atrial fibrillation in autonomically decentralized, anesthetized dogs.
    Hirose M, Furukawa Y, Nagashima Y, Lakhe M, Chiba S.
    J Pharmacol Exp Ther; 1997 Nov 29; 283(2):478-87. PubMed ID: 9353360
    [Abstract] [Full Text] [Related]

  • 3. Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart.
    Hirose M, Furukawa Y, Lakhe M, Chiba S.
    Eur J Pharmacol; 1998 May 22; 349(2-3):269-76. PubMed ID: 9671107
    [Abstract] [Full Text] [Related]

  • 4. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
    Ekblad E, Sundler F.
    Eur J Pharmacol; 1997 Sep 03; 334(1):61-6. PubMed ID: 9346329
    [Abstract] [Full Text] [Related]

  • 5. Effects of PACAP-38 on the SA nodal pacemaker activity in autonomically decentralized hearts of anesthetized dogs.
    Hirose M, Furukawa Y, Nagashima Y, Yamazaki K, Hoyano Y, Chiba S.
    J Cardiovasc Pharmacol; 1997 Feb 03; 29(2):216-21. PubMed ID: 9057071
    [Abstract] [Full Text] [Related]

  • 6. PACAP-38 activates parasympathetic nerves in isolated, blood-perfused dog atria.
    Yonezawa T, Furukawa Y, Lakhe M, Nagashima Y, Hirose M, Chiba S.
    Eur J Pharmacol; 1996 Nov 21; 315(3):289-96. PubMed ID: 8982667
    [Abstract] [Full Text] [Related]

  • 7. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb 21; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Canine adrenal catecholamine response to VIP is blocked by PACAP-(6-27) in vivo.
    Gaspo R, Lamarche L, de Champlain J, Yamaguchi N.
    Am J Physiol; 1997 May 21; 272(5 Pt 2):R1606-12. PubMed ID: 9176354
    [Abstract] [Full Text] [Related]

  • 12. Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.
    Parkman HP, Pagano AP, Ryan JP.
    Am J Physiol; 1997 Jun 21; 272(6 Pt 1):G1433-8. PubMed ID: 9227479
    [Abstract] [Full Text] [Related]

  • 13. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K.
    Endocrinology; 1997 Jun 21; 138(6):2515-20. PubMed ID: 9165043
    [Abstract] [Full Text] [Related]

  • 14. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 21; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 15. Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum.
    Fujimiya M, Yamamoto H, Kuwahara A.
    Am J Physiol; 1998 Oct 21; 275(4):G731-9. PubMed ID: 9756504
    [Abstract] [Full Text] [Related]

  • 16. Pituitary adenylate cyclase activating polypeptide stimulates release of peptide YY.
    Zhang T, Gomez G, Yanaihara N, Mochizuki T, Thompson JC, Greeley GH.
    Am J Physiol; 1993 Jun 21; 264(6 Pt 1):E933-7. PubMed ID: 8101430
    [Abstract] [Full Text] [Related]

  • 17. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs.
    Seki Y, Suzuki Y, Baskaya MK, Kano T, Saito K, Takayasu M, Shibuya M, Sugita K.
    Eur J Pharmacol; 1995 Mar 14; 275(3):259-66. PubMed ID: 7768293
    [Abstract] [Full Text] [Related]

  • 18. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
    Narita M, Furukawa Y, Takei M, Murakami M, Ren LM, Karasawa Y, Chiba S.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):166-70. PubMed ID: 2072292
    [Abstract] [Full Text] [Related]

  • 19. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide.
    Champion HC, Santiago JA, Garrison EA, Cheng DY, Coy DH, Murphy WA, Ascuitto RJ, Ross-Ascuitto NT, McNamara DB, Kadowitz PJ.
    Ann N Y Acad Sci; 1996 Dec 26; 805():429-41; discussion 442. PubMed ID: 8993422
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway.
    Rossato M, Nogara A, Gottardello F, Bordon P, Foresta C.
    Endocrinology; 1997 Aug 26; 138(8):3228-35. PubMed ID: 9231772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.